Impact of a Gene Test for Susceptibility to Lung Cancer in Smokers

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

March 31, 2013

Conditions
Smoking Cessation
Interventions
GENETIC

Respiragene test and risk score

This 12 gene test used with other data (family history, age and spirometry result) to calculate lifetime risk of lung cancer in smokers who do not quit smoking. This intervention is expected to be a motivator to quit.

Trial Locations (1)

KT17 4BL

The Integrated Care Partnership The Old Cottage Hospital Alexandra Road,, Epsom

All Listed Sponsors
collaborator

University of Surrey

OTHER

collaborator

Lab 21, Cambridge

UNKNOWN

collaborator

NHS Research and Development

OTHER_GOV

lead

Sussex NHS Research Consortium

OTHER_GOV